TY - JOUR
T1 - Reporting standards for the imaging-based diagnosis of renal masses on CT and MRI
T2 - a national survey of academic abdominal radiologists and urologists
AU - For the Society of Abdominal Radiology Disease Focused Panel on Renal Cell Carcinoma
AU - Davenport, Matthew S.
AU - Hu, Eric M.
AU - Smith, Andrew D.
AU - Chandarana, Hersh
AU - Hafez, Khaled
AU - Palapattu, Ganesh S.
AU - Stuart Wolf, J.
AU - Silverman, Stuart G.
AU - Davenport, Matthew
AU - Chandarana, Hersh
AU - Silverman, Stuart
AU - Israel, Gary
AU - Leyendecker, John
AU - Vikram, Raghu
AU - Raman, Steve
AU - Remer, Erick
AU - Smith, Andrew
AU - Wang, Jane
N1 - Funding Information:
Members of the SAR Disease-Focused Panel on Renal Cell Carcinoma: Matthew Davenport MD (Project Lead), University of Michigan Health System; Hersh Chandarana MD (DFP Co-Chair), NYU Langone Medical Center; Stuart Silverman MD (DFP Co-Chair), Brigham and Women's Hospital; Gary Israel MD, Yale New Haven Hospital; John Leyendecker MD, UT Southwestern Medical Center; Ivan Pedrosa MD, UT Southwestern Medical Center; Raghu Vikram MD, MD Anderson Cancer Center; Steve Raman MD, UCLA Medical Center; Erick Remer MD, Cleveland Clinic; Andrew Smith MD PhD, University of Mississippi Medical Center; Jane Wang MD, UCSF Medical Center.
Publisher Copyright:
© 2016, Springer Science+Business Media New York.
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Purpose: To define important elements of a structured radiology report of a CT or MRI performed to evaluate an indeterminate renal mass. Methods: IRB approval was waived for this multi-site prospective quality improvement study. A 35-question survey investigating elements of a CT or MRI report describing a renal mass was created through an iterative process by the Society of Abdominal Radiology Disease-Focused Panel on renal cell carcinoma. Surveys were distributed to consenting abdominal radiologists and urologists at nine academic institutions. Consensus within and between specialties was defined as ≥70% agreement. Respondent rates were compared with Chi Square test. Results: The response rate was 68% (117/171; 55% [39/71] urologists, 78% [78/100] radiologists). Inter-specialty consensus was that the following were essential: mass size with comparison to prior imaging, mass type (cystic vs. solid), presence of fat, presence of enhancement, and radiologic stage. Urologists were more likely to prefer the Nephrometry score (75% [27/36] vs. 22% [17/76], p < 0.0001), quantitative reporting of enhancement on CT (85% [32/38] vs. 46% [36/77], p < 0.0001), and mass position with respect to the renal polar lines (67% [24/36] vs. 36% [27/76], p = 0.002). There was inter-specialty consensus that the Bosniak classification for cystic masses was preferred. Most urologists (60% [21/35]) preferred management recommendations be omitted for solid masses or Bosniak III–IV cystic masses. Conclusions: Important elements to include in a CT or MRI report of an indeterminate renal mass are critical diagnostic features, the Bosniak classification if relevant, and the most likely specific diagnosis when feasible; including management recommendations is controversial.
AB - Purpose: To define important elements of a structured radiology report of a CT or MRI performed to evaluate an indeterminate renal mass. Methods: IRB approval was waived for this multi-site prospective quality improvement study. A 35-question survey investigating elements of a CT or MRI report describing a renal mass was created through an iterative process by the Society of Abdominal Radiology Disease-Focused Panel on renal cell carcinoma. Surveys were distributed to consenting abdominal radiologists and urologists at nine academic institutions. Consensus within and between specialties was defined as ≥70% agreement. Respondent rates were compared with Chi Square test. Results: The response rate was 68% (117/171; 55% [39/71] urologists, 78% [78/100] radiologists). Inter-specialty consensus was that the following were essential: mass size with comparison to prior imaging, mass type (cystic vs. solid), presence of fat, presence of enhancement, and radiologic stage. Urologists were more likely to prefer the Nephrometry score (75% [27/36] vs. 22% [17/76], p < 0.0001), quantitative reporting of enhancement on CT (85% [32/38] vs. 46% [36/77], p < 0.0001), and mass position with respect to the renal polar lines (67% [24/36] vs. 36% [27/76], p = 0.002). There was inter-specialty consensus that the Bosniak classification for cystic masses was preferred. Most urologists (60% [21/35]) preferred management recommendations be omitted for solid masses or Bosniak III–IV cystic masses. Conclusions: Important elements to include in a CT or MRI report of an indeterminate renal mass are critical diagnostic features, the Bosniak classification if relevant, and the most likely specific diagnosis when feasible; including management recommendations is controversial.
KW - Renal cell carcinoma
KW - Renal mass
KW - Reporting standards
KW - Society of Abdominal Radiology
KW - Structured reporting
UR - http://www.scopus.com/inward/record.url?scp=84996844932&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84996844932&partnerID=8YFLogxK
U2 - 10.1007/s00261-016-0962-x
DO - 10.1007/s00261-016-0962-x
M3 - Article
C2 - 27878338
AN - SCOPUS:84996844932
SN - 2366-004X
VL - 42
SP - 1229
EP - 1240
JO - Abdominal Radiology
JF - Abdominal Radiology
IS - 4
ER -